Gu, J. J., Hernandez-Ilizaliturri, F. J., Kaufman, G. P., Czuczman, N. M., Mavis, C., Skitzki, J. J., & Czuczman, M. S. (2013). The novel proteasome inhibitor carfilzomib (CFZ) induces cell cycle arrest, apoptosis and potentiates the anti-tumour activity of chemotherapy in rituximab-resistant lymphoma.

Gu, Juan J., Francisco J. Hernandez-Ilizaliturri, Gregory P. Kaufman, Natalie M. Czuczman, Cory Mavis, Joseph J. Skitzki, und Myron S. Czuczman. The Novel Proteasome Inhibitor Carfilzomib (CFZ) Induces Cell Cycle Arrest, Apoptosis and Potentiates the Anti-tumour Activity of Chemotherapy in Rituximab-resistant Lymphoma. 2013.

Gu, Juan J., et al. The Novel Proteasome Inhibitor Carfilzomib (CFZ) Induces Cell Cycle Arrest, Apoptosis and Potentiates the Anti-tumour Activity of Chemotherapy in Rituximab-resistant Lymphoma. 2013.